Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Paradigm Biopharmaceuticals Ltd. has issued 40 million fully paid ordinary shares without disclosure under the Corporations Act, affirming compliance with all relevant regulations. The Melbourne-based company is focused on advancing its late-stage drug developments, particularly its injectable treatment for diseases like osteoarthritis and mucopolysaccharidosis.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
